Skip to main content
Green Cross Holdings logo

Green Cross Holdings — Investor Relations & Filings

Ticker · 005250 ISIN · KR7005250006 KO Manufacturing
Open in API
Filings indexed 268 across all filing types
Latest filing 2026-06-01 Governance Information
Country KR South Korea
Listing KO 005250

About Green Cross Holdings

https://www.gccorp.com/eng/index

Green Cross Holdings is a holding company operating as a global leader in the health industry. The company's business is structured across four primary segments: Biopharma, Diagnosis, Consumer Health, and Digital Healthcare. The Biopharma division specializes in the development and manufacturing of biological medications, including blood plasma derivatives and vaccines. The Diagnosis segment offers a range of services from clinical trials to specialized testing. The Consumer Health division provides products for daily wellness, such as health functional foods and injections. The Digital Healthcare unit delivers health services through a digital platform, aiming to provide more accessible care. The company focuses on innovation in drug development and expanding its role across the healthcare spectrum from treatment to diagnostics and preventative care.

Recent filings

Filing Released Lang Actions
기업지배구조보고서공시
Governance Information Classification · 90% confidence The document is a detailed corporate governance report (“기업지배구조 보고서”) including governance policies, board composition, compliance metrics, and internal control procedures. It is not an announcement or certification, but the full governance report itself. This matches the Governance Information category (CGR).
2026-06-01 Korean
[기재정정]타법인주식및출자증권처분결정(종속회사의주요경영사항)
Regulatory Filings Classification · 85% confidence The document is a Korean regulatory disclosure detailing the subsidiary’s major management matter — specifically, a decision to dispose of equity securities (sale of shares in Curevo, Inc.). It is not an annual or quarterly report, earnings release, nor an investor presentation, and it does not fit financing, dividend, proxy, or board change categories. It is a substantive regulatory announcement of a corporate transaction (disposal of investment) and not merely a publication notice. As there is no more specific category for divestitures of investment securities, we classify it under the general Regulatory Filings (RNS) catch-all category.
2026-05-27 Korean
타법인주식및출자증권처분결정(종속회사의주요경영사항)
Transaction in Own Shares Classification · 70% confidence The document is a formal corporate announcement (in Korean) disclosing the decision by 녹십자홀딩스’s subsidiary to sell its entire stake in Curevo, Inc. It includes details on the number of shares, disposal amount, board resolution date, and related financial metrics. This is not a financial report, audit, or management change notice, but rather a transaction in the company’s own shareholdings (sale of shares held). Under the provided taxonomy, such a disclosure fits “Transaction in Own Shares (POS).”
2026-05-27 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서” (Quarterly Report) for the period January 1 to March 31, 2026, and contains detailed financial statements, segment information, risk disclosures, and other substantive data for the quarter. It clearly represents an interim/quarterly financial report itself, not merely an announcement or certification. Therefore, it should be classified as an Interim/Quarterly Report. Q1 2026
2026-05-15 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 91% confidence The document is titled “최대주주등소유주식변동신고서” which translates to “Report of changes in shareholdings of the largest shareholder etc.” It details the exact number and percentage changes of shares held by the major shareholder and related parties over specific dates, matching a notification of changes in significant share ownership. This corresponds to the Major Shareholding Notification category (MRQ).
2026-04-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a Korean “임원ㆍ주요주주 특정증권등 소유상황보고서” filed with the Securities and Futures Commission and Korea Exchange, detailing shareholdings and trades by an executive (허진성) in GC Holdings. It reports insider purchases of common stock over a series of dates. This corresponds to a Director’s Dealing / insider transaction report.
2026-04-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.